NEW YORK (GenomeWeb News) – Molecular diagnostics company Exosome Diagnostics has raised $5 million, it disclosed in a document filed with the US Securities and Exchange Commission last week.

The New York-based firm declined to comment, but in its amended Form D filed with the SEC it said that in total it is targeting $6 million in the offering. The type of securities offered is a mixture of debt; options, warrants or other rights to acquire another security; and security to be acquired upon exercise of an option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.